The antipoverty vaccines (Q24290719)

The burden of malaria epidemics and cost-effectiveness of interventions in epidemic situations in Africa.

Europe PubMed Central

title

The antipoverty vaccines (English)

0 references

author

Peter J. Hotez

series ordinal

1

0 references

author name string

Meghan T Ferris

series ordinal

2

0 references

language of work or name

English

0 references

publication date

26 July 2006

0 references

published in

Vaccine

0 references

volume

24

0 references

issue

31-32

0 references

page(s)

5787-99

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The Millennium Project: a plan for meeting the Millennium Development Goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Medicine. The need for a global HIV vaccine enterprise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Malaria vaccine development: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The Development and Impact of Tuberculosis Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Population ecology of intestinal helminth infections in human communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Evidence for an association between hookworm infection and cognitive function in Indonesian school children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Moderate to heavy infections ofTrichuris trichiuraaffect cognitive function in Jamaican school children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Extending the benefits of deworming for development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

New technologies for the control of human hookworm infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Schistosomes: the road from host-parasite interactions to vaccines in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Expressive and receptive language functioning in preschool children with prenatal cocaine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Cognitive outcomes of preschool children with prenatal cocaine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Development of immunopharmacotherapy against drugs of abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Malaria during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Hookworm infection in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Hookworm and anaemia prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The effects of maternal helminth and malaria infections on mother-to-child HIV transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Chagas disease in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Chagas' disease: study of congenital transmission in cases of acute maternal infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon- gamma in response to parasite antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Syphilis in children: congenital and acquired

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Mortality associated with congenital syphilis in the United States, 1992-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Visceral leishmaniasis (kala-azar) and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Maternal and perinatal outcome with drug abuse in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Adverse perinatal outcome in parturients who use crack cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Reproductive risks of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Dracunculiasis eradication: the final inch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Functional impairment caused by lymphatic filariasis in rural areas of south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Economic evaluation of Mectizan distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The deadly hookworm. Why did the Puerto Ricans die?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Do intestinal nematodes affect productivity in adulthood?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Achieving the Millennium Development Goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Worms can worsen malaria: towards a new means to roll back malaria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Fighting tropical diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Towards a recombinant antigen vaccine against Onchocerca volvulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Future directions for vaccine-related onchocerciasis research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The genome of the protist parasite Entamoeba histolytica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Comparative genomics of trypanosomatid parasitic protozoa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

From genome to vaccines for leishmaniasis: Screening 100 novel vaccine candidates against murine Leishmania major infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Recent progress in vaccines for amebiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

A virulence attenuated amoebapore-less mutant of Entamoeba histolytica and its interaction with host cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Immunotherapy of Trypanosoma cruzi infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

New approaches in vaccine development for parasitic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The Trypanosoma cruzi proteome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Second-generation vaccines against leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Genome and proteome analysis of Chlamydia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Genome scale identification of Treponema pallidum antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Prospects for vaccine development against Buruli disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

New steps toward eliminating blinding trachoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Delivery of Chlamydia vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Vaccines for sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

The role of BCG in prevention of leprosy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Progress towards an effective syphilis vaccine: the past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

New developments in flavivirus vaccines with special attention to yellow fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Cost-effectiveness of a pediatric dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Development of Orphan Vaccines: An Industry Perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Health Innovation Networks to Help Developing Countries Address Neglected Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Priority setting and the 'neglected' tropical diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

inferred from DOI database lookup

7 January 2021

based on heuristic

The impact of Chagas disease control in Latin America: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.008